Narayana Hrudayalaya Limited (NH) Net Income 2023–TTM

Name: Narayana Hrudayalaya Limited (NH) net income history 2023-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-10-22

Narayana Hrudayalaya Limited annual net income for fiscal TTM was ₹8.2 billion, an increase of 1.3% from ₹8.1 billion in fiscal 2026. All figures are reported results from public filings — no estimates or projections.

NH Annual Net Income

Net Income (annual)	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Net Income	₹8.2B	₹8.1B	₹7.9B	₹7.9B	₹6.1B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NH Quarterly Net Income

Net Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net Income	₹2.1B	₹2.2B	₹1.3B	₹2.6B	₹2.0B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

MANIPALHOS Net Income — Manipal Health Enterprises Limited
MAXHEALTH Net Income — Max Healthcare Institute Limited
ASTERDM Net Income — Aster DM Quality Care Limited
FORTIS Net Income — Fortis Healthcare Limited
MEDANTA Net Income — Global Health Limited
BDMS Net Income — Bangkok Dusit Medical Services Public Company Limited

More NH metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow

All NH financial statements → Interactive NH charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.